Definitive radiation therapy for endometrial cancer in medically inoperable elderly patients

Brachytherapy

Volumn 9, Issue 3, 2010, Pages 260-265

  Wegner, Rodney E ^a   Beriwal, Sushil ^a   Heron, Dwight E ^a   Richard, Scott D ^b   Kelly, Joseph L ^b   Edwards, Robert P ^b   Sukumvanich, Paniti ^b   Zorn, Kristin K ^b   Krivak, Thomas C ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Elderly; Endometrial cancer; HDR brachytherapy

Indexed keywords

AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMORBIDITY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HUMAN; PRIORITY JOURNAL; RADIATION DOSE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; RADIATION INJURIES; TREATMENT OUTCOME;

EID: 77954956906     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.08.013     Document Type: Article

References (23)

1. American Cancer Society Cancer facts and figures 2007, American Cancer Society, Atlanta, GA, 4.
2. McMeekin S.D., Alektiar K.M., Sabbatini P. Principles and practice of gynecologic oncology 2009, 683-732. Lippincott Williams & Wilkins, Philadelphia, PA. 5th ed. R.R. Barakat, M. Makman, M. Randall (Eds.).
3. Keys H.M., Roberts J.A., Brunetto V.L., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 2004, 92:744-751.
4. Scholten A.N., van Putten W.L., Beerman H., et al. Postoperative radiotherapy for stage 1 endometrial carcinoma: Long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 2005, 63:834-838.
5. Patanaphan V., Salazer O.M., Chougule P. What can be expected when radiation therapy becomes the only curative alternative for endometrial cancer?. Cancer 1985, 55:1462-1467.
6. Taghian A., Pernot M., Hoffstetter S., et al. Radiation therapy alone for medically inoperable patients with adenocarcinoma of the endometrium. Int J Radiat Oncol Biol Phys 1988, 15:1135-1140.
7. U.S.Bureau of the Census Current population reports, special studies, P23-190, 65+ in the United States 1996, U.S. Government Printing Office, Washington, DC.
8. Modesitt S.C., van Nagell J.R. The impact of obesity on the incidence and treatment of gynecologic cancers: A review. Obstet Gynecol Surv 2005, 60:683-692.
9. Rose P.G., Baker S., Kern M., et al. Primary radiation therapy for endometrial carcinoma: A case controlled study. Int J Radiat Oncol Biol Phys 1993, 27:585-590.
10. Rouanet P., Dubois J.B., Gely S., et al. Exclusive radiation therapy in endometrial carcinoma. Int J Radiat Oncol Biol Phys 1993, 26:223-228.
11. Coon D., Beriwal S., Heron D.E., et al. High-dose rate Rotte " Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results. Int J Radiat Oncol Biol Phys 2008, 71:779-783.
12. Chenery S.G., Pla M., Podgorsak E.B. Physical characteristics of the Selectron high dose rate intracavitary afterloader. Br J Radiol 1985, 58:735-740.
13. Roman T.N., Souhami L., Freeman C.R., et al. High dose rate afterloading intracavitary therapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1991, 20:921-926.
14. Selke P., Roman T.N., Souhami L., et al. Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993, 27:803-809.
15. Pla C. Fast intracavitary and interstitial treatment planning in brachytherapy 2. In: Mould RF, editor. Proceedings of the Brachytherapy Working Conference, 5th International Selectron User's Meeting. The Hague, The Netherlands:1988. p. 109-120.
16. U.S. Census Bureau. Population Estimates Program, April 1, 2000, and July 1, 2005.
17. Orton C.G. High dose rate versus low dose rate brachytherapy for gynecological cancer. Semin Radiat Oncol 1993, 3:232-239.
18. Chao C.K.S., Grigsby P.W., Perez C.A., et al. Brachytherapy related complications for medically inoperable stage I endometrial carcinoma. Int J Radiat Oncol Biol Phys 1995, 31:37-42.
19. Knocke T.H., Kucera H., Weidinger B., et al. Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: Results of 12 years of experience with 280 patients. Int J Radiat Oncol Biol Phys 1997, 37:359-365.
20. Kucera H., Knocke T.H., Kucera E., et al. Treatment of endometrial carcinoma with high-dose-rate brachytherapy alone in medically inoperable stage I patients. Acta Obstet Gynecol Scand 1998, 77:1008-1012.
21. Niazi T.M., Souhami L., Portelance L., et al. Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma. Int J Radiat Oncol Biol Phys 2005, 63:1108-1113.
22. Nguyen T.V., Petereit D.G. High-dose-rate brachytherapy for medically inoperable stage I endometrial cancer. Gynecol Oncol 1998, 71:196-203.
23. Beriwal S., Kim H., Heron D.E., et al. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer. Technol Cancer Res Treat 2006, 5:521-527.